Apnimed (APMD) Return on Assets ROA from the second quarter of 2026 to second quarter of and for the year 2026, Average High and Low, Fundamental Ratios from Jun 30 2026 to - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Apnimed, Inc.  (Nasdaq: APMD)


Apnimed's ROA from the second quarter of 2026 to the second quarter of and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Apnimed's ROA in the second quarter of 2026?
Apnimed, Inc. achieved a return on average assets (ROA) of 142.41 % in its second quarter of 2026, this is above APMD's average return on assets of 0%.
Apnimed, Inc. assets over the 12 months ending in its second quarter of 2026 are valued at $67 million

ROA has improved compared to -166.87% in the second quarter of 2026, due to net income growth.

However, within the Healthcare sector Apnimed, Inc. achieved the highest return on assets. While the total ranking for ROA unchanged, relative to the second quarter of 2026 at no. .

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
II. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
II. Quarter
Y / Y Total Assets Change - - - - -
Y / Y Net Income Change - - - - -
Net Income (TTM) in million 96 -30 -98 -29 0
Return On Assets (TTM) 142.41 % -166.87 % - - -
APMD's Total Ranking # # # # #
Total Assets (TTM) in million 195 73 0 0 0
Seq. Total Assets Change 168.21 % - - - -
Seq. Net Income Change 85.97 % - - - -

APMD's 5 Years Annual ROA >> Back to APMD Management Effectiveness >> Compare APMD ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Assets Statistics
High Average Low
0 %
0 %
0 %
 





Financial Statements
Apnimed's Assets $ 195 million APMD's Balance sheet
Apnimed's Income $ 126 million Quarterly APMD's Income Statement
APMD's Income by Division See APMD's Income by Division



Annual Return On Assets
FY
FY
FY
FY
FY
Y / Y Total Assets Change - - - - -
Total Assets in million 0 0 0 0 0
Y / Y Net Income Change - - - - -
Net Income in million 0 0 0 0 0
Annual Return On Assets - - - - -

APMD's 5 Years Annual ROA >> Back to APMD Management Effectiveness >> Compare APMD ROA to its Competitors



More Return On Assets Ratios
APMD's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
APMD's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for APMD's Competitors
Subscribers only: Roa for Apnimed's Suppliers
Subscribers only: Return On Assets for APMD's Customers

You may also want to know
APMD's Roi APMD's Inventory Turnover Ratio APMD's Growth Rates APMD's Dividend Comparisons
APMD's Profitability Ratios APMD's Asset Turnover Ratio APMD's Dividend Growth
APMD's Roe APMD's Valuation Ratios APMD's Financial Strength Ratios APMD's Dividend Payout Ratio



Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector ROA
Kyntra Bio Inc   156.80 %
Vor Biopharma Inc   154.23 %
Glucotrack Inc   151.40 %
Capforce Inc   141.40 %
Protagenic Therapeutics Inc new  137.58 %
Elutia Inc   108.72 %
Silexion Therapeutics Corp  99.09 %
Quince Therapeutics Inc   88.46 %
Interpace Biosciences Inc   85.91 %
Arbutus Biopharma Corp  82.34 %
Oncotelic Therapeutics Inc   81.75 %
Advanced Biomed Inc.  76.09 %
Rigel Pharmaceuticals Inc  72.27 %
Actinium Pharmaceuticals Inc  71.73 %
Exelixis Inc   70.51 %
Rallybio Corporation  64.51 %
Oramed Pharmaceuticals Inc  64.18 %
Fortress Biotech Inc   60.88 %
Atlantic Coastal Acquisition Corp Ii  54.09 %
Lensar Inc   47.48 %
Elite Pharmaceuticals Inc   46.11 %
Omeros Corporation  46.05 %
Q32 Bio Inc   45.18 %
Aurinia Pharmaceuticals Inc   44.95 %
Agenus Inc  44.86 %
Earth Science Tech Inc   44.02 %
Escalon Medical Corp   42.96 %
Sanuwave Health Inc   39.15 %
Liquidia Corporation  36.30 %
Ironwood Pharmaceuticals inc   34.34 %

Date modified: 2026-10-19T03:48:40+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.